The emergence of amivantamab offers a exciting development for patients battling cancers with c-MET overexpression. This unique molecule, a precise inhibitor of both MET kinase plus human epidermal growth factor https://kaleufzt668998.blog5.net/92142471/amivantamab-a-promising-solution-for-c-met-associated-cancers